88 reports

Merck KGaA is one of the world' s leading providers of prescription drugs, over-the-counter pharmaceuticals and specialty chemical products.

  • Biosimilar
  • Market Size
  • Allergan plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Global Biosimilars and Follow-On Biologics Market 2019-2029 ## Report Overview ##. ## Biosimilar Overview ##. ## Biosimilars Market Segmentation ##. ## Why You Should Read this Report ##. ## How this Report Delivers ##. ## Main Questions Answered by this Report ##. ## Who is this Report for?

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

PART D OF MEDICARE COVERS ACCESS TO PRESCRIPTION DRUGS.

  • Biosimilar
  • United States
  • World
  • Amgen Inc.
  • Eli Lilly & Co.

REV PRESS., ##(##), PP. ##-##.

  • Biosimilar
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.

BMJ SPECIALIST JOURNALS, ##(SUPPL ##), P.

  • Biosimilar
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • PHARMACEUTICAL MARKET - MARKET SEGMENTS

nvpm=##|##||||##||| ##|##|##|##|##|##|##|##|## [Accessed on June ##, 2018] BIBLIOGRAPHY Pharmaceutical Market - US-China Trade War Global Data (2018).

  • Biosimilar
  • United States
  • Market Size
  • Medtronic, Inc.
  • Zimmer Biomet Holdings, Inc.

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Market Size

Boehringer-Ingelheim is another company to proceed with one of the largest biomanufacturing projects.

  • Biosimilar
  • World
  • Demand
  • Market Size
  • Supply

ELSEVIER; ##-##.

  • Biosimilar
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group

The business in prescription medicines is Boehringer Ingelheim' s most important mainstay.

  • Biosimilar
  • World
  • Boehringer Ingelheim GmbH
  • Lonza Group Ltd
  • Samsung Electronics Co., Ltd.

Biosimilars in Oncology Report Code: GDHCHT## Published: August 2018 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

The safety of one switch is fine.

  • Biosimilar
  • United States
  • Forecast
  • AbbVie Inc.
  • Eli Lilly & Co.

These agents are available as overthe-counter medications such as Ibuprofen and aspirin as well as prescription drugs.

  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.

However, it will negatively impact the prescription drug market share, General reimbursement challenges which is much more important for the market growth.

  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

Spending Patterns for Prescription Drugs Under Medicare Part D.

  • Biosimilar
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Low ## Low F.

  • Biosimilar
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.
  • Global Adalimumab Biosimilar Market Forecast 2017-2024
  • Developments in the US Biosimilar Landscape: Rebate I

UBS; ##-##.

  • Biosimilar
  • Amgen Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • Pfizer Inc.

IT OFFERS THERAPEUTIC AND PREVENTIVE HEALTH SOLUTIONS THROUGH PRESCRIPTION MEDICINES, VACCINES, BIOLOGIC THERAPIES AND ANIMAL HEALTH PRODUCTS.

  • Biosimilar
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • KEY EVENTS IMPACTING SALES FOR ULCERATIVE COLITIS IN THE UK, 2015-2025
  • KEY EVENTS IMPACTING SALES FOR ULCERATIVE COLITIS IN JAPAN, 2015-2025

UNIVERSAL HEALTHCARE WILL HELP ENSURE THAT CITIZENS WHO REQUIRE PRESCRIPTION DRUGS WILL HAVE ACCESS TO THEM, THEREBY INCREASING PRESCRIPTION DRUG USE OVERALL.

  • Biosimilar
  • Market Size
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group

You can easily book an appointment with one online.

  • Biosimilar
  • World
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.

THESE POTENTIAL TARGETS COULD ALLOW A WIDER CHOICE FOR THOSE NONRESPONDING TO NSAIDS OR TNF INHIBITORS ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## NumberofDrugs Source: GlobalData, Pharma Intelligence Center [Accessed May 2018] PIPELINE PRODUCTS - REVIEW DESIG

  • Biosimilar
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • 7.6.3 SANDOZ INTERNATIONAL GMBH - MAJOR BIOSIMILARS APPROVED FOR MARKETING
  • 6.4.1 REIMBURSEMENT OF BIOSIMILARS IN GERMANY

Note: ##.

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • PFIZER SWOT ANALYSIS IN RA, 2015-2025

ENBREL IS ONE OF THE TOP TWO PRESCRIPTION DRUGS IN TERMS OF GLOBAL SALES, SECOND ONLY TO ABBVIE' S HUMIRA.

  • Biosimilar
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group
  • INDUSTRY

SKIN THERAPY LETTER; ##(##): ##-##.

  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

PLOS ONE; ##(##): E##.

  • Biosimilar
  • United States
  • Allergan plc
  • Novartis AG
  • Ophthotech Corporation

Glucose levels and intraocular pressure are measured today, but just one measurement at a time in the doctor' s office.

  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

ENBREL IS ONE OF THE TOP TWO PRESCRIPTION DRUGS IN TERMS OF GLOBAL SALES, SECOND ONLY TO ABBVIE' S HUMIRA.

  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • Pfizer Inc.
  • Remicade group

The FDA has set a Prescription Drug User Fee Act (PDUFA) action date of Feb. ##, 2018 (Amgen, press release, June ##, 2017).

  • Biosimilar
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group

Not just to inject one and another one and another one with Ozurdex. "

  • Biosimilar
  • AbbVie Inc.
  • Clearside Biomedical, Inc.
  • pSivida Corp.
  • Santen Pharmaceutical Co., Ltd.
  • BIOSIMILAR MANUFACTURERS & OPERATING MARGINS
  • MAJOR STAKEHOLDERS

MEDICARE PART D, WHICH COVERS PRESCRIPTION DRUGS, CURRENTLY HAS A WIDE COVERAGE GAP.

  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.